Related Experiment Video

Updated: Aug 15, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Basis and clinical significance of regression of hypertensive hypertrophy

W Motz, J Zähringer, B E Strauer

    Basic Research in Cardiology
    |January 1, 1986
    PubMed

    Insights

    Normalizing blood pressure with antihypertensive drugs is key for treating hypertensive heart disease. These medications can reduce left ventricular hypertrophy, improve heart muscle blood flow, and enhance heart function.

    Area of Science:

    • Cardiology
    • Hypertension Research
    • Cardiac Physiology

    Background:

    • Hypertensive heart disease (HHD) management focuses on blood pressure normalization.
    • Antihypertensive therapy is crucial for mitigating cardiac complications in HHD.

    Purpose of the Study:

    • To outline the role of antihypertensive drugs in managing hypertensive heart disease.
    • To detail the impact of blood pressure normalization on cardiac structure and function.

    Main Methods:

    • Review of therapeutic strategies for hypertensive heart disease.
    • Analysis of the effects of antihypertensive medications on cardiac parameters.

    Main Results:

    • Antihypertensive drugs are essential for blood pressure normalization in HHD.
    • Therapeutic interventions can lead to regression of left ventricular hypertrophy.
    • Improved myocardial perfusion and left ventricular function are observed with treatment.

    Conclusions:

    • Blood pressure normalization via antihypertensive drugs is fundamental in HHD therapy.
    • Treatment strategies should address regression of cardiac changes and functional improvement.
    • Management aims to cover clinical therapy for common hypertensive cardiac complications.

    More Related Videos

    A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats07:31

    A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

    Published on: December 2, 2016

    Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

    Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

    Published on: May 26, 2022

    Related Concept Videos

    Hypertension and Regulation of Blood Pressure01:18

    Hypertension and Regulation of Blood Pressure

    Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Hypertension II: Pathophysiology01:29

    Hypertension II: Pathophysiology

    Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    Cellular Adaptation II: Hypertrophy01:26

    Cellular Adaptation II: Hypertrophy

    Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...